China Pharma Holdings (CPHI) Cash & Equivalents Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | -39.02% |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 120.45% |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn | 12.78% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 50.32% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -32.64% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 138.97% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 37.30% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -12.11% |
| 10 | China Pharma Holdings | 32.39 Mn | 32.22 Mn | 285,487.00 | -59.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.18% |
| Dec 31, 2025 | -44.95% |
| Sep 30, 2025 | -62.76% |
| Jun 30, 2025 | -15.46% |
| Mar 31, 2025 | -50.80% |
| Dec 31, 2024 | -55.97% |
| Sep 30, 2024 | -47.54% |
| Jun 30, 2024 | -18.03% |
| Mar 31, 2024 | -28.11% |
| Dec 31, 2023 | -29.86% |
| Sep 30, 2023 | -34.77% |
| Jun 30, 2023 | -59.00% |
| Mar 31, 2023 | -68.59% |
| Dec 31, 2022 | -58.22% |
| Sep 30, 2022 | 320.00% |
| Jun 30, 2022 | 22.22% |
| Mar 31, 2022 | 594.97% |
| Dec 31, 2021 | 407.39% |
| Sep 30, 2021 | 42.86% |
| Jun 30, 2021 | -0.75% |